Advisory firms back proposals requiring AmerisourceBergen to manage opioid risks
The endorsements from the advisory firms mark a significant step in an investor coalition's battle to force companies to be more responsive.
Two major shareholder advisory firms are recommending that AmerisourceBergen (ABC) stockholders support a proposal to require the pharmaceutical wholesaler to report the steps being taken to manage financial and reputational risks associated with the opioid crisis.
The firms — Glass Lewis and Institutional Shareholder Services — also recommend shareholders back a proposal to disclose if its board claws back compensation from senior
